(Q40225124)

18 September 2017

Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA. (English)

1 reference

18 September 2017

7

Michael Weller

1 reference

18 September 2017

6

Hans-Georg Rammensee

1 reference

18 September 2017

5

Ingmar Hoerr

1 reference

18 September 2017

Birgit Scheel

1

1 reference

18 September 2017

Steffen Aulwurm

2

1 reference

18 September 2017

Jochen Probst

3

1 reference

18 September 2017

Lothar Stitz

4

1 reference

18 September 2017

Steve Pascolo

8

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

European Journal of Immunology

18 September 2017

1 reference

18 September 2017

36

1 reference

18 September 2017

2807-2816

1 reference

18 September 2017

10

1 reference

Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases

18 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Coley's toxins, tumor necrosis factor and cancer research: a historical perspective

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

The danger model: a renewed sense of self

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Of mice and men: species variations of Toll-like receptor expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Immunostimulating capacities of stabilized RNA molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200635910

7 January 2021

Identifiers

DOI

10.1002/EJI.200635910

1 reference

18 September 2017

1 reference